Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients | Journal of Translational Medicine User montaukwhaler, in the non small cell lung cancer subreddit, 09 Mar 2023